跳至主要内容
临床试验/RBR-5q6x56k
RBR-5q6x56k已完成2 期

Follow up of outpatients with heart failure with reduced ejection fraction via WhatsApp during the COVID-19 pandemic

Hospital Geral Roberto Santos0 个研究点开始时间: 2022年3月28日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Patients were eligible for inclusion if they were 18 years of age or older, had heart failure with an ejection fraction less than or equal to 40%, regardless of etiology, assessed by an echocardiogram performed within a maximum of six months before randomization, functional class I- III (New York Heart Association), optimized drug therapy, cell phone with access to the Whatsapp® application.

排除标准

  • Patients with any non-cardiac condition that, in the investigator's opinion, leads to a life expectancy of less than 12 months, functional class IV (NYHA), cardiogenic shock, cardiac surgery within the previous 8 weeks, heart transplant waiting list, failure chronic kidney disease, uncontrolled high blood pressure, inability to understand or interact with text messages due to illiteracy, cognitive impairment or social problems, severe depression and uncontrolled arrhythmia.

研究者

发起方
Hospital Geral Roberto Santos

相似试验